sapropterin dihydrochloride — CareFirst (Caremark)
6-pyruvoyl-tetrahydropterin synthase (6-PTS) deficiency
Initial criteria
- Member is age ≥ 1 month
- Diagnosis confirmed for one of the listed biopterin metabolic defects
- Medication prescribed by or in consultation with a physician who specializes in the treatment of metabolic disease and/or PKU
Reauthorization criteria
- Member experiencing benefit from therapy as evidenced by disease stability or improvement
Approval duration
Initial 6 months; reauthorization 6 months